CBS 2019
CBSMD教育中心
中 文

DAPT Duration

Abstract

Recommended Article

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIThe STOPDAPT-2 Randomized Clinical Trial DAPT, Our Genome and Clopidogrel 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction
|<< 1 2 3 4 5 6 7 ...>>|

JOURNAL：CBS2017 Article Link

向世界发出中国心声——TCT2017系列报道一

CBS2017


美国丹佛——当地时间10月29日上午11时00到11时30分， Peter Block医生在TCT（经导管心血管治疗学术会议）的举办地Colorado Convention Center， ACCEL办公室对远赴重洋，来自中国的DK Crush系列研究负责人陈绍良教授进行了一次深入的专访。此次访问紧密围绕DKCRUSH-V 对治疗冠脉左主干动脉真性远端分叉病变的双对吻挤压技术 (the double kissing crush techniques)与单支架技术(provisional side branch stenting)这一大规模多中心临床随机对照试验展开。






介入器械的日趋成熟并未彻底攻克冠脉分叉病变这一心血管重大疾病难点，不同的治疗策略亟需高信度、高水平的试验设计进行比较，并进一步接受全球临床的实战检验。为此，陈绍良团队历时十载，一直致力于此，持之以恒地探索治疗左主干分叉病变的可靠疗法，期待我国的创新可以为全球病患带去福音。






TCT2017重要日程预告



TCT2017作为冠脉左主干病变处理、生物可吸收支架、经导管瓣膜病治疗领域的顶尖专业盛会，将汇集12项最新揭晓临床试验（LBCTs）和16项首次报道研究（FRIs）结果在本次大会上揭晓。南京市第一医院陈绍良教授团队的DKCRUSH-V研究作为最值得关注的成果之一，将于当地时间10月30日11时40分（北京时间11月1日凌晨1点40分）在TCT2017主会场发布。南京市第一医院将分别于当地时间11月1日上午8时在主会场和10:00在冠脉分会场进行前后两次手术转播，分别演示经皮肺动脉去交感神经术（PADN）治疗原发性肺动脉高压、双对吻挤压术治疗左主干末端分叉病变技术，两场手术均由陈绍良教授担任主要术者。





>CBS CBS 2019

> CBS 2019 REGISTRATION

> CBS 2019 PROGRAM

> CBS 2019 CALL FOR SCIENCE

> CBS 2019 SPOTLIGHTS

 CBSMD

> CBSMD WEBSITE REGISTRATION

> EDUCATION CENTER

> RECOMMANDED PAPER

> TOP 10 RESEARCH PAPER

> PRE-READING

CBS 2019 CBS 2019 FACULTY Education Resource CBSMD Scientific Library
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top